Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Australia becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 vaccine
mRNA-1273.214, an Omicron-containing bivalent vaccine, has demonstrated significantly higher antibody titers against all tested variants, including Omicron BA.1 and BA.4/5 subvariants
Moderna expects to supply mRNA-1273.214 to Australia in September
https://finance.yahoo.com/news/therapeutic-goods-administration-provisionally-approves-050000742.html
SWISSMEDIC AUTHORIZES MODERNA’S OMICRON-TARGETING BIVALENT BOOSTER CANDIDATE, MRNA-1273.214
https://investors.modernatx.com/news/news-details/2022/Swissmedic-Authorizes-Modernas-Omicron-Targeting-Bivalent-Booster-Candidate-MRNA-1273.214/default.aspx
MODERNA TO HOST R&D DAY ON THURSDAY, SEPTEMBER 8, 2022
“Brazil receives first batch of tecovirimat to treat monkeypox”
https://olhardigital.com.br/2022/08/29/medicina-e-saude/brasil-recebe-primeiro-lote-de-tecovirimat-para-tratamento-da-variola-dos-macacos/
Baby hospitalized after testing positive for monkeypox
Officials said the infant in Washington State was exposed to the virus by an infected family member and is now being treated with an authorized anti-viral called TPOXX in a Seattle hospital.
If an INFANT is receiving TPOXX therapy in a hospital in Washington, that tells you ALL YOU NEED TO KNOW about risk/ benefit. TPOXX DESERVES IMMEDIATE EUA.
https://abcnews.go.com/WNT/video/baby-hospitalized-testing-positive-monkeypox-88948234
The Palm Springs hospital received both oral and IV forms of the medication on Aug. 22, explained Dr. Claudia Fortiche, manager of the research program at Desert Regional. The oral medication, typically three tablets taken twice a day, is the preferred treatment method, Foriche said, but an IV is available for patients who are experiencing painful mouth lesions that make it difficult to swallow. Once a patient is able to swallow, the CDC recommends that they switch to the oral form, Foriche said.
https://eu.desertsun.com/story/news/health/2022/08/26/desert-regional-medical-center-now-providing-tpoxx-medication-monkeypox-infections/7905491001/
$SIGA
A UC Davis Health study finds that the antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. The study is one of the earliest studies to assess and report the outcomes of treating patients with monkeypox with this antiviral.
https://health.ucdavis.edu/coronavirus/news/headlines/uc-davis-health-study-reports-on-the-safety-efficacy-of-tecovirimat-in-treating-monkeypox/2022/08
Brazil's health agency just approved the exemption to register to import Tpoxx.
https://www.plenglish.com/news/2022/08/26/anvisa-authorizes-use-of-vaccine-and-drug-against-monkeypox-in-brazil/
RNA for Moderna’s Omicron Booster Manufactured by CIA-Linked Company
https://2ndsmartestguyintheworld.substack.com/p/rna-for-modernas-omicron-booster?r=91goq&utm_medium=ios
Moderna believes that Pfizer and BioNTech's COVID-19 vaccine Comirnaty® infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology. This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax®. Pfizer and BioNTech copied this technology, without Moderna's permission, to make Comirnaty®.
https://investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioNTech-for-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platform/default.aspx
Monkeypox medicine tecovirimat will be available in New Zealand from late September.
https://www.1news.co.nz/2022/08/26/monkeypox-medicine-secured-by-govt-for-late-september/
All the cards in this game haven’t been played yet!
big news imminent....loading!
MODERNA COMPLETES APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR EMERGENCY USE AUTHORIZATION OF OMICRON-TARGETING BIVALENT COVID-19 BOOSTER VACCINE, MRNA-1273.222
https://investors.modernatx.com/news/news-details/2022/Moderna-Completes-Application-To-U.S.-Food-And-Drug-Administration-For-Emergency-Use-Authorization-Of-Omicron-Targeting-Bivalent-Covid-19-Booster-Vaccine-mRNA-1273.222/default.aspx
They have started enrollment on a clinical trial of TPOXX in the UK. The name of the trial is PLATINUM.
https://platinumtrial.ox.ac.uk
$SIGA winner
VCU Medical Center lowers barriers to access monkeypox treatment Tpoxx
Removing obstacles facing our community
August 22, 2022
$SIGA
https://www.vcuhealth.org/news/vcu-medical-center-lowers-barriers-to-access-monkeypox-treatment
The PLATINUM trial, funded by a 3.7 million pound ($4.35 million) UK government grant, aims to recruit at least 500 participants. Participants will either be given a 14-day course of tecovirimat twice daily, or a placebo.
To assess the drug's effectiveness, the rate at which lesions heal, the time taken until patients test negative for the virus, and the proportion of patients who require hospitalisation due to complications will be tracked.
"I'm hoping that we can have a result before Christmas, but it depends on the rate of recruitment," said Sir Peter Horby, Professor of Emerging Infections and Global Health at the University of Oxford and the director of the new Pandemic Sciences Institute.
https://www.reuters.com/business/healthcare-pharmaceuticals/british-scientists-behind-key-covid-trial-launch-study-test-monkeypox-treatment-2022-08-23/?taid=6304afb3b596c2000132a321&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter
August 22, 2022 huge$
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection
https://jamanetwork.com/journals/jama/fullarticle/2795743?guestAccessKey=300cc546-00c4-47df-99d6-0a606da1e210&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=082222
$SIGA winner
MONKEYPOX NEWS. TOPXX
MONKEYPOX NEWS: In the coming weeks, #NIAID plans to initiate clinical trials evaluating the antiviral tecovirimat (TPOXX) for #monkeypox and a clinical trial evaluating dose-sparing regimens of JYNNEOS, a vaccine approved to prevent monkeypox. Read more https://t.co/jtHxVdcXSd pic.twitter.com/IQf5zBgHJN
— NIAID News (@NIAIDNews) August 22, 2022
In addition to the COVID vaccines generating enormous profits today, the company has four infectious-disease vaccines in late-stage clinical trials. Later this year, we'll also see if Moderna has a chance at expanding beyond vaccines and into the treatment of rare diseases and cancer!!!!!!!!
MODERNA TO SUPPLY 12 MILLION DOSES OF OMICRON-CONTAINING BIVALENT COVID-19 BOOSTER VACCINES TO THE GOVERNMENT OF CANADA
https://investors.modernatx.com/news/news-details/2022/Moderna-to-Supply-12-Million-Doses-of-Omicron-Containing-Bivalent-COVID-19-Booster-Vaccines-to-the-Government-of-Canada/default.aspx
On the ninth day of symptoms, he began treatment with oral tecovirimat, 600 mg twice daily. His pain improved within the following 36 hours, and no new skin lesions formed.He reported no adverse effects!
$SIGA winner
https://www.acpjournals.org/doi/10.7326/L22-0300#.YwJT1IpL37o.twitter
we go back again $200 Keep selling it down people as they load up the truck with $3B of fresh powder under the buyback program!!!!!!!
remenber: (mRNA-4157) Phase 1 ongoing; Phase 2 fully enrolled, data expected in 4Q 2022 rna cancer
TPOXX Is the Only Treatment Available for Monkeypox—Here's What To Know
https://www.health.com/news/tpoxx-monkeypox-treatment
this is normal, before launch!
The 50,000 placement of courses Monday will give rise to the final US approval of SIGA treatment
news: And officials outlined new efforts to make the treatment for monkeypox, Tpoxx, easier to access.
"Next week, HHS will be pre-positioning 50,000 courses of Tpoxx across the country. That's nearly five times as many treatment courses than confirmed cases in the US. These courses will be made available to jurisdictions where the outbreak is most severe so that individuals can get treatment more quickly from their healthcare providers," Fenton said.
The allocation will rely on a formula based 75% on the number of cases in a jurisdiction and 25% on the number of individuals at risk.
https://www.weny.com/story/47116994/first-on-cnn-biden-officials-accelerating-monkeypox-vaccine-effort-with-18-million-additional-doses-and-other-steps
Institutional Shares -29,101,384 39.85% new!
Keep selling it down people as they load up the truck with $3B of fresh powder under the buyback program!!!!!!! RELAX
JAMES MOCK JOINS MODERNA AS CHIEF FINANCIAL OFFICER
https://investors.modernatx.com/news/news-details/2022/James-Mock-Joins-Moderna-as-Chief-Financial-Officer/default.aspx
Clinical trials for Siga Technologies Inc.’s monkeypox treatment will start as early as next week in the UK as the outbreak continues to grow, the company’s chief scientific officer told Bloomberg Law.
The UK studies will mark the first of a dozen clinical trial sites to launch around the world under the latest outbreak, Dennis E. Hruby, Siga’s executive vice president and chief scientific officer, said in an interview Tuesday.
US studies run by the National Institutes of Health are set to follow mid-September, and Canada isn’t far behind, he added.
"At some point a large volumw but will take place"
"the Stock market is a place which transfers money FROM the Impatient TO the Patient" , So be patient.
$SIGA winner
https://news.bloomberglaw.com/pharma-and-life-sciences/uk-to-begin-sigas-monkeypox-drug-trials-as-soon-as-next-week
Smallpox vaccines may not protect against monkeypox for life:
https://amp.theguardian.com/world/2022/aug/15/smallpox-vaccines-protect-monkeypox-hiv-erode
TPOXX treatment is the only solution to the current and any future Pox outbreaks. The vaccines for these types of viruses are complicated and not reliable enough to consistently work. winner$$$
Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK
Moderna, Inc.
Mon, August 15, 2022,
Up....
Moderna says construction of its new mRNA vaccine factory in Laval, Que. will begin later this year, with production expected to begin by the end of 2024.
It will be the pharmaceutical giant's first manufacturing facility outside the United States and cost an estimated $180 million to construct.
https://www.cbc.ca/news/canada/montreal/moderna-vaccine-facility-laval-1.6548396